While its safety profile was consistently favorable, the largest Phase IIb trial failed to show statistical significance for weight loss, and commercial development was halted in 2007.[2] Despite this, interest in AOD-9604 has continued in the compounding pharmacy and integrative medicine space, particularly given its safety data, its lack of IGF-1 stimulation, and emerging research around joint health
L-leucine: Triggers mTOR and protein synthesis
However, its important to consider FDA-approved treatments and speak with your healthcare provider to determine the best treatment for your individual needs for blood sugar control and/or your weight loss journey
We verify our products with third-party, FDA-registered agencies to ensure identity, quality, strength, and purity
If you know that you are allergic to any components of Neurobion Forte RF Injection, do not use this product